Search

everythinglearnresearchcommunity

for

Search:↓

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

Expand access to prevention and address barriers for sex workers in Kostanay.

Expanding premarital screening to include skin conditions, STDs, infertility, and male disorders can improve marriage stability.

New tools were created to help lupus patients report their symptoms and impacts more accurately.

Pediatric dermatologists need to understand the unique skin health needs of LGBTQIA youth to provide better care.

Serotonergic antidepressants can significantly increase the risk of erectile dysfunction and have a small risk of causing irreversible sexual dysfunction.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

The document concludes that a new questionnaire to assess mental health in alopecia patients shows low rates of seeking mental health services and support groups.

Childhood sexual trauma, especially between ages 5-7, is linked to lower cortisol levels in adult hair, suggesting long-term stress response changes.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

New grading scale accurately measures hair loss severity and treatment effectiveness.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

Long-term treatment with finasteride or combined therapy worsens sexual function in men with urinary issues.

Wheat straw is valuable for its health benefits and various industrial uses.

Treating hematospermia can improve sexual function and reduce anxiety.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

The Spanish version of the Hair Specific Skindex-29 is a reliable tool for measuring quality of life in Spanish-speaking women with hair loss.

SSRI antidepressants can cause long-lasting sexual problems.

Addressing personal and moral aspects can improve sexual satisfaction.

Flibanserin may help improve sexual symptoms in various conditions beyond its approved use.

Hair loss lowers quality of life, causing embarrassment, frustration, and sexual rejection.

The Greek DCQ is a reliable and valid tool for assessing dysmorphic concern.

The new measure helps understand the personal and emotional impact of hair loss in alopecia areata patients.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

The survey helps identify menstrual irregularities and excess male hormones, aiming to detect conditions like Polycystic Ovary Syndrome.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

HIV-positive patients, especially men who have sex with men, had a high rate of skin diseases and sexually transmitted infections.

Testosterone therapy can help postmenopausal women with low sexual desire if monitored carefully.

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.